Quantcast

Latest Rosuvastatin Stories

2010-07-26 13:04:28

The European Society of Cardiology (ESC) is concerned that interpretations of a paper about cholesterol, published in the Lancet (1), could act to deter ongoing research efforts into developing new therapeutic strategies to increase high density lipoprotein (HDL) cholesterol.  Caution, the ESC experts advise, should be displayed in the interpretation of the results. In the Lancet study, Paul Ridker and colleagues, from Brigham and Women's Hospital (Boston, MA, USA), undertook a...

2010-06-29 18:06:00

WILMINGTON, Del., June 29 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that Judge Joseph Farnan, Jr., US District Court, District of Delaware, has found that the substance patent protecting CRESTOR (RE37,314 - the '314 patent) is valid and enforceable. In its ruling, the court found that no inequitable conduct was committed by any Shionogi employee. The court also held the '314 patent to be non-obvious and properly reissued. (Logo:...

d1b7f19a553a506e973e96fa47fdc01f1
2010-06-29 11:00:00

On Monday, researchers said they did not find evidence that cholesterol-reducing drugs can help extend the life of patients at risk of heart disease. The study involved 65,229 people who were questioned about the use of the cholesterol-reducing drugs, also known as statins.  Statins are the world's top-selling prescription drugs.  According to health industry data firm IMC Health, over 238 million prescriptions for cholesterol-lowering drugs were dispensed by retail pharmacies in...

2010-06-29 05:00:00

Analyzes the Effectiveness and Safety of Statin Use for Those Who Need It Recommendations for Choosing a 'Best Buy' Statin and Strategies for Money-Saving YONKERS, N.Y., June 29 /PRNewswire-USNewswire/ -- A series of new reports from Consumer Reports Best Buy Drugs (BBD) caution that the benefits of statin use by children and some women may not outweigh the risks. Drugs to lower cholesterol -- including statins -- are the most commonly prescribed drugs in the U.S. and garnered more than...

2010-06-21 07:00:00

MONTGOMERY, Ala. and INDIANAPOLIS, June 21 /PRNewswire-FirstCall/ -- Kowa Pharmaceuticals America, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that LIVALO® (pitavastatin) tablets is now available in retail pharmacies throughout the United States. LIVALO, a statin medication approved by the U.S. Food and Drug Administration (FDA) in August 2009 is indicated for adults as an adjunctive therapy to diet for the treatment of primary hyperlipidemia or mixed...

2010-05-26 07:00:00

ATLANTA, May 26 /PRNewswire/ -- Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., announced today that the investigational new drug PSD502, a topical metered dose spray which is being developed for the treatment of primary premature ejaculation (PE), will be the subject of five clinical presentations early next month. These data will be presented at the American Urological Association's (AUA) 2010 Annual Meeting May 29 to June 3 in San Francisco. The...

2010-05-05 17:27:00

NEW YORK, May 5 /PRNewswire-FirstCall/ -- Pfizer's Viagra and AstraZeneca's Nexium took the top-two slots on the new L2 Digital IQ Index for pharmaceutical brands, a first-of-its kind measurement of the digital competence of 51 pharma brands across eight therapeutic categories, designed to provide an actionable metric to optimize pharmaceutical digital ROI. The ranking, created by think tank L2 in partnership with leading media agency PHD Network, evaluated pharmaceutical brands'...

2010-04-27 01:00:00

LONDON, April 27 /PRNewswire/ -- CRESTOR(TM) (rosuvastatin) has been approved in nineteen countries within the EU for the prevention of major cardiovascular events in patients who are at high risk* of having a first cardiovascular event. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/astrazeneca/43661/ (Photo: http://www.newscom.com/cgi-bin/prnh/20100427/MM93313) This new indication is based on subgroup data from the landmark...

2010-04-21 07:00:00

WALTHAM, Mass., April 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a dyslipidemia drug that is dosed once a week would earn 40 percent patient share in the U.S., according to surveyed U.S. primary care physicians (PCPs). In contrast, in Europe, such a drug would earn 23 percent patient share, according to surveyed European physicians. These estimated patient shares are comparable to shares...

2010-03-30 07:02:00

WILMINGTON, Del. and ABBOTT PARK, Ill., March 30 /PRNewswire-FirstCall/ -- AstraZeneca and Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD(TM) (rosuvastatin / fenofibric acid delayed release) Capsules. The companies are currently evaluating the CRL, will continue discussions with the FDA to determine next steps with respect to the CERTRIAD NDA and will respond to the...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related